Overview
Portfolio 2
| Date | Name | Website | Total Raised | Location |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Apr 17, 2023 | Caristo Diagnostics | caristo.com | $16.3M | United Kingdom, England, Oxford |
Mentions in press and media 18
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Apr 21, 2026 | Lightcast Secures Major Funding, Redefines Single-Cell Analysis with Envisia Platform | Lightcast, a life science innovator, secured $27 million in funding. ARCH Venture Partners led the round. This capital fuels the 2026 commercial launch of its Envisia™ benchtop platform. Envisia marks a significant leap in single-cell analy... |
| Apr 15, 2026 | Lightcast Raises $27M in Funding | Lightcast, a Cambridge, UK-based life science tools company focused on functional single-cell analysis, raised $27M in funding. The round was led by ARCH Venture Partners with participation from M Ventures, Illumina Ventures, +ND Capital, L... |
| Apr 14, 2026 | Lightcast Raises $27 Million and Adds Industry Veteran to Accelerate Commercialization of Envisia™ Platform | · Proceeds will help enhance workflows and expand single-cell functional assay portfolio · Brad Crutchfield joins as advisor to support early access growth and global launch CAMBRIDGE, England – April 14, 2026 – Lightcast, a pioneering life... |
| Aug 25, 2025 | Oxford-based OrganOx achieves one of the UK’s largest medtech exits at $1.5 billion valuation | OrganOx, an Oxford-based medtech company that developed technology to preserve donor livers outside the human body, has been acquired in a deal valued at $1.5 billion. This marks one of the UK’s largest medtech exits and delivers £175 milli... |
| Aug 25, 2025 | OrganOx achieves one of the UK’s largest medtech exit to date | OrganOx, the Oxford-based medtech company behind pioneering liver perfusion technology that has transformed transplant outcomes worldwide, has been acquired in a deal valued at approximately $1.5 billion. The transaction also delivered BGF’... |
| Feb 24, 2025 | OrganOx Closes $142M Equity Financing | OrganOx, an Oxford, UK-based organ medical technology company, raised $142M in equity funding. The round was led by new investor HealthQuest Capital with participation from existing investors BGF and Lauxera Capital Partners, along with add... |
| Apr 6, 2024 | Biofidelity Secures €22M in Funding: A Game-Changer in Genomic Technology | Cambridge-based Biofidelity, a genomic technology company, has just locked in a hefty €22M in funding, propelling its total funding to a staggering €55.3M. This cash injection, led by key investors like Octopus Ventures and Agilent Technolo... |
| Apr 3, 2024 | Biofidelity Raises $24M in Funding | Biofidelity, a Cambridge, UK- and Morrisville, NC-based genomic technology company, raised $24M in funding. Backers included Agilent Technologies, Octopus Ventures, BlueYard Capital, and Longwall Ventures. Led by Dr. Barnaby Balmforth, CEO,... |
| Apr 28, 2023 | Wayland Additive – raises £4.6m in latest funding round | We are delighted to announce our latest investment into Wayland Additive, as part of a £4.6m funding round. This latest investment will increase Wayland’s in-house production capability delivering more machines and materials to its customer... |
Reviews 0
FAQ about Longwall Ventures
How many startups has Longwall Ventures invested in?
Longwall Ventures has 2 portfolio companies on Parsers VC, among them Caristo Diagnostics.
What has the press written about Longwall Ventures?
Parsers VC has collected 18 articles mentioning Longwall Ventures, among them “Lightcast Secures Major Funding, Redefines Single-Cell Analysis with Envisia Platform” (Apr 21, 2026) and “Lightcast Raises $27M in Funding” (Apr 15, 2026).
Is Longwall Ventures still active?
Yes, Longwall Ventures is active; its latest activity on Parsers VC dates from May 22, 2026.